机译:使用生物密合并术语评价免疫球蛋白克麦芽淋巴瘤患者患者的免疫球蛋白克隆基因重排的诊断价值
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Oral &
Maxillofacial Surg Hangzhou Zhejiang;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Oral &
Maxillofacial Surg Hangzhou Zhejiang;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Pathol Hangzhou Zhejiang Peoples R China;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Oral &
Maxillofacial Surg Hangzhou Zhejiang;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Oral &
Maxillofacial Surg Hangzhou Zhejiang;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Oral &
Maxillofacial Surg Hangzhou Zhejiang;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Oral &
Maxillofacial Surg Hangzhou Zhejiang;
Zhejiang Univ Affiliated Hosp 1 Coll Med Dept Oral &
Maxillofacial Surg Hangzhou Zhejiang;
机译:使用生物密合并术语评价免疫球蛋白克麦芽淋巴瘤患者患者的免疫球蛋白克隆基因重排的诊断价值
机译:BIOMED-2协议可检测台湾南部B细胞和T细胞淋巴瘤的克隆免疫球蛋白和T细胞受体基因重排。
机译:根据BIOMED-2协议评估IGK和IGL分子基因重排用于霍奇金淋巴瘤的临床诊断
机译:腮腺癌多式化治疗患者功能因素和生活质量评价,包括放射治疗
机译:皮肤T细胞淋巴瘤中叠加克隆γT细胞受体基因重排分析
机译:BIOMED-2多重免疫球蛋白/ T细胞受体聚合酶链反应协议可以可靠地取代常规印迹诊断中的Southern印迹分析
机译:原发性干燥综合征患者诊断性唇腺活检的生殖器中心不能预测腮腺MALT淋巴瘤的发展